Modifications of Behavior and Inflammation in Mice Following Transplant with Fecal Microbiota from Children with Autism.


Journal

Neuroscience
ISSN: 1873-7544
Titre abrégé: Neuroscience
Pays: United States
ID NLM: 7605074

Informations de publication

Date de publication:
21 08 2022
Historique:
received: 03 03 2022
revised: 23 06 2022
accepted: 28 06 2022
pubmed: 7 7 2022
medline: 31 8 2022
entrez: 6 7 2022
Statut: ppublish

Résumé

Autism spectrum disorder (ASD) is a neurodevelopmental disorder displaying the modification of complex human behaviors, characterized by social interaction impairments, stereotypical/repetitive activities and emotional dysregulation. In this study, fecal microbiota transplant (FMT) via gavage from autistic children donors to mice, led to the colonization of ASD-like microbiota and autistic behaviors compared to the offspring of pregnant females exposed to valproic acid (VPA). Such variations seemed to be tightly associated with increased populations of Tenericutes plus a notable reduction (p < 0.001) of Actinobacteria and Candidatus S. in the gastrointestinal region of FMT mice as compared to controls. Indeed altered behaviors of FMT mice was reported when evaluated in the different maze tests (light dark, novel object, three chamber tests, novel cage test). Contextually, FMT accounted for elevated expression levels of the pro-inflammatory factors IL-1β, IL-6, COX-1 and TNF-α in both brain and small intestine. Villous atrophy and inflammatory infiltration (Caspase 3 and Ki67) were increased in the small intestine of FMT and VPA mice compared to controls. Moreover, the observed FMT-dependent alterations were linked to a decrease in the methylation status. Overall, findings of the present study corroborate a key role of gut microbiota in ASD. However, further investigations are required before any possible manipulation of gut bacteria with appropriate diets or probiotics can be conducted in ASD individuals.

Identifiants

pubmed: 35792193
pii: S0306-4522(22)00341-4
doi: 10.1016/j.neuroscience.2022.06.038
pii:
doi:

Substances chimiques

Valproic Acid 614OI1Z5WI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-189

Informations de copyright

Copyright © 2022 IBRO. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ennio Avolio (E)

Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomic, University of Roma "Tor Vergata", Rome, Italy; Health Center srl, Via Sabotino 56, 87100 Cosenza, Italy; Laboratory of Comparative Neuroanatomy, Department of Biology, Ecology and Earth Science (DiBEST), University of Calabria, Cosenza, Italy.

Ilaria Olivito (I)

Laboratory of Comparative Neuroanatomy, Department of Biology, Ecology and Earth Science (DiBEST), University of Calabria, Cosenza, Italy.

Eleonora Rosina (E)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Lorenzo Romano (L)

Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomic, University of Roma "Tor Vergata", Rome, Italy.

Tommaso Angelone (T)

Laboratory of Cardiovascular Physiology, Department of Biology, Ecology & Earth Science, University of Calabria, Italy.

Anna De Bartolo (A)

Laboratory of Cardiovascular Physiology, Department of Biology, Ecology & Earth Science, University of Calabria, Italy.

Manuel Scimeca (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Dina Bellizzi (D)

Department of Biology, Ecology and Earth Sciences (DiBEST), University of Calabria, 87036 Rende, Italy.

Patrizia D'Aquila (P)

Department of Biology, Ecology and Earth Sciences (DiBEST), University of Calabria, 87036 Rende, Italy.

Giuseppe Passarino (G)

Department of Biology, Ecology and Earth Sciences (DiBEST), University of Calabria, 87036 Rende, Italy.

Raffaella Alò (R)

Laboratory of Comparative Neuroanatomy, Department of Biology, Ecology and Earth Science (DiBEST), University of Calabria, Cosenza, Italy.

Rosa Maria Facciolo (RM)

Laboratory of Comparative Neuroanatomy, Department of Biology, Ecology and Earth Science (DiBEST), University of Calabria, Cosenza, Italy.

Claudia Bagni (C)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.

Antonino De Lorenzo (A)

Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomic, University of Roma "Tor Vergata", Rome, Italy.

Marcello Canonaco (M)

Laboratory of Comparative Neuroanatomy, Department of Biology, Ecology and Earth Science (DiBEST), University of Calabria, Cosenza, Italy. Electronic address: marcello.canonaco@unical.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH